Literature DB >> 27476763

Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?

Qing-Lei Zeng1, Zhi-Qin Li1, Hong-Xia Liang1, Guang-Hua Xu2, Chun-Xia Li2, Da-Wei Zhang3, Wei Li4, Chang-Yu Sun1, Fu-Sheng Wang5, Zu-Jiang Yu6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27476763     DOI： 10.1016/j.jhep.2016.07.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy.

Authors:  N Saraiya; A C Yopp; N E Rich; M Odewole; N D Parikh; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2018-05-30       Impact factor: 8.171

2.  Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma.

Authors:  Chong Wu; Jie Lin; Yulan Weng; Dan-Ni Zeng; Jing Xu; Shufeng Luo; Li Xu; Mingyu Liu; Qiaomin Hua; Chao-Qun Liu; Jin-Qing Li; Jing Liao; Cheng Sun; Jian Zhou; Min-Shan Chen; Chao Liu; Zhenhong Guo; Shi-Mei Zhuang; Jin-Hua Huang; Limin Zheng
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  Drug Treatment for Chronic Hepatitis C Infection and Cancer Risk.

Authors:  Marcus-Alexander Wörns; Peter Robert Galle; Stefan Zeuzem; Peter Schirmacher; Michael Manns; Arndt Vogel
Journal:  Dtsch Arztebl Int       Date:  2017-09-04       Impact factor: 5.594

Review 4.  AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.

Authors:  Amit G Singal; Joseph K Lim; Fasiha Kanwal
Journal:  Gastroenterology       Date:  2019-03-13       Impact factor: 22.682

5.  Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study.

Authors:  Ahmed Kamal; Amr Aly Abd Elmoety; Yousri Abdelmeguid Rostom; Mohamed Said Shater; Sameh Aldesoky Lashen
Journal:  Clin Exp Hepatol       Date:  2021-03-11

6.  Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.

Authors:  Giuliano Ramadori; Patrizia Bosio; Federico Moriconi; Ihtzaz A Malik
Journal:  BMC Cancer       Date:  2018-03-06       Impact factor: 4.430

7.  Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs.

Authors:  Mohamed Tharwat Hegazy; Walaa Ramadan Allam; Mohamed A Hussein; Naguib Zoheir; Luca Quartuccio; Sherif F El-Khamisy; Gaafar Ragab
Journal:  EBioMedicine       Date:  2018-08-20       Impact factor: 8.143

Review 8.  Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.

Authors:  Page Axley; Zunirah Ahmed; Sujan Ravi; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2017-12-17

Review 9.  Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.

Authors:  Maria Guarino; Anna Sessa; Valentina Cossiga; Federica Morando; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

Review 10.  Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.

Authors:  C Nelson Hayes; Peiyi Zhang; Yizhou Zhang; Kazuaki Chayama
Journal:  Viruses       Date:  2018-09-28       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.